In this episode, Macklin and Giovanis discuss the power of math and collaboration in cancer research.

A promising study shows that certain may more safely help detect and treat cancer. Researchers tested several types of tiny iron oxide particles—similar to those already approved by the FDA for other uses—to see how they affect the body and where they travel after injection.

2025 Symposium: Improving Breast Cancer Outcomes // Revealing and Targeting Immune Interaction

JKTG-funded project aims to answer question: Why do cancer cells selectively colonize in the liver?

In the new episode of Driving Research, Ted talks with Dr. Laura Heiser (OHSU) about treating the toughest cancers—and how teaming up with JKTG brought unexpected lessons, in and out of the lab.

New project reflects JKTG focus on building collaborative research to fast-track cancer breakthroughs

New podcast, Driving Research hosted by Ted Giovanis, features conversations with the scientists/clinicians partnering with the JKTG Foundation to change the way we discover, diagnose, and treat cancer.

This year’s event, titled Improving Breast Cancer Outcomes: Revealing and Targeting Tumor-Immune Interactions, will take place October 15, 2025, in Washington, D.C.

Ted Giovanis was invited to speak at Johns Hopkins University as part of the 2025 Leading Change: Perspectives from Outside of Medicine Conversation Series, hosted by Dr. Elliot K. Fishman. In his talk, titled “Data, Risk, Adaptation, Resilience – What Real Life Experiences Can Tell Us About Health Care Today,” 

The Jayne Koskinas Ted Giovanis Foundation for Health and Policy (JKTG Foundation) today announced funding to better understand how and why some breast cancer spreads, or metastasizes, to the lungs, resulting in possible new treatments for breast cancer patients. The four-year project, receiving just under $1M, will be led by Charles Perou, Ph.D., professor of Genetics and Pathology at the University of North Carolina Lineberger Comprehensive Cancer Center in Chapel Hill.